[Stable coronary heart disease--lessons from the COURAGE Study. With intensive drug therapy on the success track].
D015906:Angioplasty, Balloon, Coronary; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001384:Azetidines / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000401:mortality / Q000628:therapy*; D023921:Coronary Stenosis / Q000401:mortality / Q000628:therapy*; D016757:Death, Sudden, Cardiac / Q000453:epidemiology / Q000517:prevention & control; D000069438:Ezetimibe; D006801:Humans; D053208:Kaplan-Meier Estimate; D008019:Life Style; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control; D010043:Outcome and Process Assessment, Health Care; D016032:Randomized Controlled Trials as Topic; D019821:Simvastatin / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D001384:Azetidines; D002317:Cardiovascular Agents; D019821:Simvastatin; D000069438:Ezetimibe